Pilonidal Disease
Conditions
Brief summary
This study aims to investigate the effect of laser ablation (LA) in minimally invasive management of pilonidal disease (PD). Data of the patients with PD who were eligible for simple debridement have been prospectively collected since March 2018, when laser ablation treatment came into use in our institution. Laser ablation treatment was offered to all eligible patients. All the patients underwent debridement (removal of hair and/or necrotic tissues through pits using a clamp/curette/brush) of PD; LA was added to the procedure in patients who were willing to have LA. The surgical outcome of two procedures was compared. The primary outcome measure was recurrence at 36 months.
Interventions
DEVICELaser ablation
A diode-laser that has been reported to be safe and effective in several treatments including pilonidal disease, anal fistula, hemorrhoids, and vascular ablation was used to obtain shrinkage of pilonidal cyst
Sponsors
Istanbul Medipol University Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patients with Class III, IV, and V pilonidal disease according to Tezel Navicular Area Classification * Patients who underwent debridement for pilonidal disease
Exclusion criteria
* Patients with acute abscess (Tezel Class II) * Antibiotic use within 4 weeks before surgery * Patients lost to follow-up at 3,7 and 30 days; 6, 12 and 36 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| disease recurrence at 36 months | 36 months | Any ongoing or recurrent sypmtoms were recorded |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Complications after the procedure | 1 month | Safety of the procedure |
| Incidence of adverse events | 1 month | Safety of the procedure |
Countries
Turkey (Türkiye)
Outcome results
None listed